Exhibit 107
Calculation Of Filing Fee Tables
424(b)(5)
(Form Type)
Enanta Pharmaceuticals, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type |
Security Class Title | Fee Calculation Rule |
Amount Registered |
Proposed Maximum Offering Price Per Share |
Maximum Aggregate Offering Price(1) |
Fee Rate | Amount of Registration Fee(2) | |||||||||
| Fees to Be Paid |
Equity | Common Stock, par value $0.01 per share | 457(o) And 457(r) |
— | — | $100,000,000 | $0.0000927 | $9,270 | ||||||||
| Fees Previously Paid |
— | — | — | — | — | — | — | — | ||||||||
| Total Offering Amounts | $100,000,000 | $9,270 | ||||||||||||||
| Total Fees Previously Paid | $0 | |||||||||||||||
| Total Fee Offsets | $0 | |||||||||||||||
| Net Fee Due | $9,270 | |||||||||||||||
| (1) | The proposed maximum aggregate offering price is being used to calculate the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended. |
| (2) | Calculated in accordance with Rule 456(b) and Rule 457(r) of the Securities Act of 1933, as amended. This “Calculation of Registration Fee” table shall be deemed to update the “Calculation of Registration Fee” table in the registrant’s registration statement on Form S-3ASR filed with the Securities and Exchange Commission on August 9, 2021 (File No. 333-258632). |